Private equity firm GTCR has struck a 4.1 billion euro ($4.8 billion) deal to buy Czech generic drugmaker Zentiva from Advent International, the Financial Times reported on Wednesday, citing unidentified sources...
Novartis to acquire Tourmaline Bio in deal valuing it at $1.4 billion
Novartis will acquire Tourmaline Bio for $48 per share, valuing the New York-based biopharmaceutical company at $1.4 billion on a fully diluted basis, the Swiss pharma giant said on Tuesday. Tourmaline is focused on...
Singapore-based firm proposes to acquire 25% in Welcure Drugs & Pharma
Welcure Drugs & Pharmaceuticals Ltd on Wednesday said that Singapore-based Telexcell Trade has offered to acquire up to 25 per cent equity stake in the company at an indicative price of Rs 20 per share. This...
Aurobindo Pharma closing in on $5.5b Zentiva buyout
Aurobindo Pharma has emerged as the frontrunner to acquire Prague-based generic drugmaker Zentiva for $5-5.5 billion (Rs 43,500-47,900 crore) from Advent International, said several people aware of the matter...
Intas Pharma completes acquisition of UDENYCA biosimilar for $558 million
Intas Pharma has completed the acquisition of UDENYCA for $558 million, the company said in a release. UDENYCA is a biosimilar to Neulasta or Pegfilgrastim. It is used to treat side effects of radiation therapy in...
Orchid Pharma gets formal nod from Court of France for Allecra Therapeutics acquisition
Orchid Pharma said that the Court of France has pronounced the order in favour of the company, to acquire the assets of Allecra Therapeutics SAS with effect from 01 August 2025. On 30 July 2025, the company had...
Drug firm Aizant to soon get binding bids for controlling stake in $350-mn deal
InvAscent, the firm that manages India Life Sciences Fund, is expecting binding bids for its stake in the Hyderabad-based Aizant Drug Research Solutions Pvt. Ltd early next month. The deal, which has been in the works...
AbbVie in talks to acquire Gilgamesh Pharmaceuticals, Bloomberg News reports
Drugmaker AbbVie is in talks to acquire privately held mental health therapeutics company Gilgamesh Pharmaceuticals in a deal worth about $1 billion, Bloomberg News reported on Wednesday, citing people familiar with the...
Natco Pharma to buy over 35% in South Africa’s Adcock Ingram
Hyderabad-based Natco Pharma on Wednesday said it has agreed to buy a 35.75% stake in Adcock Ingram, South Africa’s second-largest drugmaker, for ‘2,000 crore. The all-cash deal will give Natco Pharma a...
Brookfield, EQT close in on Gland Pharma, but rising stock a pain
Buyout groups Brookfield and EQT are in active discussions to buy Hyderabad-based Gland Pharma, a contract development and manufacturing organisation (CDMO) and injectables company, from China’s Fosun Group in what...
Torrent Pharma seeks CCI nod to acquire majority stake in JB Chemicals for Rs 19,500 crore
Ahmedabad-based Torrent Pharmaceuticals has sought fair trade regulator CCI’s clearance to acquire a majority stake in in J B Chemicals and Pharmaceuticals in a Rs 19,500-crore deal. After the completion of the...
Sino Biopharmaceutical to acquire LaNova Medicines for up to $951 million
Hong Kong-listed Sino Biopharmaceutical said on Tuesday it will buy the remaining 95.09% stake it does not hold in Shanghai-based LaNova Medicines for no more than $950.92 million. The acquisition of the cancer...
